New options for untreatable coronary artery disease: angiogenesis and laser revascularization.
Some patients with severe symptomatic coronary artery disease despite maximal medical therapy are not eligible for bypass surgery or percutaneous coronary intervention, but may be eligible for two newer therapies: therapeutic angiogenesis with growth factors and transmyocardial laser revascularization.
Mukherjee
D
D
Department of Cardiology, Cleveland Clinic, USA. mukherd@ccf.org
Ellis
S G
SG
D000465:Algorithms; D000787:Angina Pectoris / Q000145:classification; D003327:Coronary Disease / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D016228:Endothelial Growth Factors / Q000627:therapeutic use*; D005346:Fibroblast Growth Factors / Q000627:therapeutic use*; D006801:Humans; D053685:Laser Therapy; D008222:Lymphokines / Q000627:therapeutic use*; D017202:Myocardial Ischemia / Q000628:therapy; D009204:Myocardial Revascularization; D020033:Protein Isoforms / Q000627:therapeutic use*; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D008222:Lymphokines; D020033:Protein Isoforms; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D005346:Fibroblast Growth Factors